Jincheng Pharmacy (300233.SZ): Mira beilong obtains approval for listing application of chemical raw materials.

Zhitan Financial News App, Jincheng Pharmaceutical (300233.SZ) announced that its wholly-owned subsidiary, Beijing Jincheng Tai'er Pharmaceutical Co., Ltd., recently received the "Chemical Raw Material Drug Listing Application Approval Notice" issued by the National Medical Products Administration. The chemical raw material drug is called Mirabegron. Mirabegron is a selective -3 adrenergic receptor agonist mainly used for the treatment of overactive bladder syndrome (OAB) including urinary incontinence, urgency, and frequency.